The FDA has classified a recall for Trividia Health's TRUE METRIX blood glucose measuring devices as Class I, indicating a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. The issue stems from owner's booklets and instructions for use that did not adequately direct lay users on how to respond to an E-5 error code, which could indicate a serious problem with the device's accuracy.

This recall impacts worldwide distribution, including the United States, Puerto Rico, Mexico, the United Kingdom, Jamaica, Trinidad & Tobago, and Australia. Healthcare providers and consumers using these devices should be aware of the potential for inaccurate readings and the lack of clear guidance on error codes. While the document does not specify a compliance deadline or direct actions for consumers, the nature of a Class I recall necessitates immediate attention from the manufacturer and distributors to mitigate risks.